Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


MEDNAX INC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/2012
Net patient service revenue1,911.191,733.951,779.761,723.113,253.393,183.162,780.002,438.912,154.011,816.61
Total Revenues1,911.191,733.951,779.761,723.113,253.393,183.162,780.002,438.912,154.011,816.61
Practice supplies and other operating expenses100.4790.6995.9192.48106.44118.4298.4889.0082.3971.82
Practice salaries and benefits1,297.481,193.941,180.761,125.672,227.342,031.221,753.511,543.401,361.321,130.91
Depreciation and amortization32.1528.4425.9324.3678.8689.2664.2345.9939.9730.82
General and administrative expenses263.36248.95244.51232.22385.86372.57305.92247.53218.21193.54
Transformational and restructuring related expenses22.1073.8060.890.00------------
Gain on sale of building7.28------------------
Total Operating Expenses1,708.271,635.821,608.001,474.722,798.502,611.472,222.131,925.911,701.881,427.09
Operating Income (Loss)202.9298.13171.76248.39454.89571.69557.87513.00452.13389.52
Interest expense68.72110.48118.9392.9574.5663.0923.118.895.423.25
Equity in earnings of unconsolidated affiliate1.911.592.277.710.953.193.131.78----
Investment income13.6517.913.693.054.392.021.842.731.701.90
Loss on early extinguishment of debt(14.53)------------------
Income (loss) before income taxes135.237.1558.78166.21385.67513.80539.73508.62448.41388.17
Income tax (benefit) provision27.2416.7316.5844.6980.23189.20204.04191.41167.90147.26
State: Current16.89(2.95)8.5615.1919.084.3020.9521.1117.0413.98
State: Deferred(10.87)7.57(10.02)(6.23)2.752.551.630.301.141.53
Federal: Current41.59(16.61)63.7065.40122.38166.76168.60167.75134.94111.94
Federal: Deferred(20.37)28.72(45.66)(29.67)(63.98)15.6012.872.2614.7819.81
Income from Continuing Operations107.99(9.58)42.21121.51305.44----------
Income from discontinued operations22.95(786.91)(1,539.91)147.1214.93----------
Net income130.94(796.49)(1,497.70)268.63320.37324.60335.69317.20280.52240.91
Net income attributable to noncontrolling interests(0.03)--------(0.32)(0.63)(0.08)----
Net Income (loss) Available to Common Shareholders130.96(796.49)(1,497.70)268.63320.37324.91336.32317.28280.52240.91
Income from continuing operations: Basic1.27(0.11)0.501.333.31----------
Income from discontinued operations:Basic0.27(9.44)(18.44)1.620.16----------
Net Earnings Per Share (Basic)1.54(9.55)(17.94)2.953.473.523.613.222.832.47
Income from continuing operations: Diluted1.26(0.11)0.501.333.29----------
Income from discontinued operations:Diluted0.27(9.44)(18.33)1.600.16----------
Net Earnings Per Share (Diluted)1.53(9.55)(17.83)2.933.453.493.583.182.782.42
Weighted Average Shares Outstanding (Basic)84.8383.4083.5091.1092.4392.4293.0898.5999.1197.39
Weighted Average Shares Outstanding (Diluted)85.8383.4084.0191.6192.9693.1193.9699.89100.9799.38